KEY FEATURES
| Full Name | Coagulation Factor Ⅸ |
|---|---|
| Synonym | F9;HEMB;P19;PTC;THPH8;Christmas Factor; |
| Assay Type | Sandwich |
| Reactivity | Mouse |
| Range | 0.16-10ng/mL |
| Sensitivity | 0.1ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Mouse F9 in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Mouse F9. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Mouse F9 and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Mouse F9, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Mouse F9. You can calculate the concentration of Mouse F9 in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Mouse F9 ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.55 | 1.6 | 4.69 | 0.54 | 1.53 | 4.77 |
| Standard deviation | 0.03 | 0.09 | 0.24 | 0.03 | 0.08 | 0.17 |
| CV(%) | 5.11 | 5.88 | 5.2 | 5.76 | 5.26 | 3.52 |
RECOVERY
The recovery of Mouse F9 spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 88-103 | 95 |
| EDTA plasma (n=8) | 84-96 | 91 |
| Cell culture media (n=8) | 94-110 | 101 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Mouse F9 in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with F9 ELISA Kits
| F10 ELISA Kit | publications with F9 and F10 |
| F12 ELISA Kit | publications with F9 and F12 |
| SERPINC1 ELISA Kit | publications with F9 and SERPINC1 |
| GGCX ELISA Kit | publications with F9 and GGCX |
Pathways associated with F9 ELISA Kit
| Blood Clotting Cascade Pathway | Blood Clotting Cascade Pathway |
| Complement And Coagulation Cascades Pathway | Complement And Coagulation Cascades Pathway |
| Extrinsic Pathway | Extrinsic Pathway |
| Formation Of Fibrin Clot (Clotting Cascade) Pathway | Formation Of Fibrin Clot (Clotting Cascade) Pathway |
| Gamma-carboxylation Of Protein Precursors Pathway | Gamma-carboxylation Of Protein Precursors Pathway |
| Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway | Gamma-carboxylation, Transport, And Amino-terminal Cleavage Of Proteins Pathway |
| Hemostasis Pathway | Hemostasis Pathway |
| Intrinsic Pathway | Intrinsic Pathway |
Diseases associated with F9 ELISA Kit
| Carcinoma | publications with F9 and Carcinoma |
| Cell Transformation, Neoplastic | publications with F9 and Cell Transformation, Neoplastic |
| Hemophilia B | publications with F9 and Hemophilia B |
| Immune System Diseases | publications with F9 and Immune System Diseases |
| Liver Diseases | publications with F9 and Liver Diseases |
| Liver Neoplasms | publications with F9 and Liver Neoplasms |
| Adenocarcinoma | publications with F9 and Adenocarcinoma |
| Mental Disorders | publications with F9 and Mental Disorders |
| Drug Toxicity | publications with F9 and Drug Toxicity |
| Cardiovascular Diseases | publications with F9 and Cardiovascular Diseases |
Organs/Tissues associated with F9 ELISA Kit
| Liver | publications with F9 and Liver |
| Uncharacterized Tissue | publications with F9 and Uncharacterized Tissue |